| Bethel Lutheran Home | |
| 1001 S Egan Ave, Madison, South Dakota 57042 | |
| (605) 256-4539 | |
| Name | Bethel Lutheran Home |
|---|---|
| Location | 1001 S Egan Ave, Madison, South Dakota |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 59 |
| Occupancy Rate | 96.78% |
| Medicare ID (CCN) | 435076 |
| Legal Business Name | Bethel Lutheran Home |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1497736615 |
| Organization Name | BETHEL LUTHERAN HOME |
| Address | 1001 S Egan Ave, Madison, SD 57042 |
| Phone Number | 605-256-4539 |
News Archive
Investigators at The Feinstein Institute for Medical Research have discovered a new genetic risk factor for schizophrenia and bipolar disorder called NDST3. The findings are published online in Nature Communications.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today reported financial results for the first quarter ended March 31, 2010. For clarity and consistency, the data presented in this release includes only the results of the Company's fingerprint-based Biometrics Division for such period. The Company completed the sale of its Law Enforcement Division on December 8, 2009.
UAB researchers have identified a therapeutic target for the treatment of acute spinal cord injuries. According to this research, conducted on mice, the administration of a drug that prevents loss of myelin - the insulating sheath around nerve fibres that allows signals to be transmitted - increases the mobility of the mice after an injury.
Researchers at Thomas Jefferson University discovered that nearly half of coronary artery bypass patients are not taking statins and aspirin together when they are referred for diagnostic cardiac catheterization at least three years after their initial bypass. Their results are currently in press online in the American Journal of Cardiology.
Researchers from Public Health England are conducting a large-scale prospective longitudinal study to determine whether healthcare workers who have previously developed coronavirus disease 2019 (COVID-19) are immune to reinfection with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Investigators at The Feinstein Institute for Medical Research have discovered a new genetic risk factor for schizophrenia and bipolar disorder called NDST3. The findings are published online in Nature Communications.
BIO-key International, Inc., a leader in finger-based biometric identification solutions, today reported financial results for the first quarter ended March 31, 2010. For clarity and consistency, the data presented in this release includes only the results of the Company's fingerprint-based Biometrics Division for such period. The Company completed the sale of its Law Enforcement Division on December 8, 2009.
UAB researchers have identified a therapeutic target for the treatment of acute spinal cord injuries. According to this research, conducted on mice, the administration of a drug that prevents loss of myelin - the insulating sheath around nerve fibres that allows signals to be transmitted - increases the mobility of the mice after an injury.
Researchers at Thomas Jefferson University discovered that nearly half of coronary artery bypass patients are not taking statins and aspirin together when they are referred for diagnostic cardiac catheterization at least three years after their initial bypass. Their results are currently in press online in the American Journal of Cardiology.
Researchers from Public Health England are conducting a large-scale prospective longitudinal study to determine whether healthcare workers who have previously developed coronavirus disease 2019 (COVID-19) are immune to reinfection with the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.1 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.02 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.71 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 5.14 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.82 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.48 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.39 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.63 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 24.21 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 7.91 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.27 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.56 | 95.98 |